Introduction
The coexistence of thyroid nodule and primary hyperparathyroidism (PHPT) presents a clinical diagnostic and management challenges. Previous investigations have reported a relatively high, but versatile, incidence of 12 to 52% of thyroid nodules in patients with PHPT 1-3 and 5 to 26% among patients with PHPT with thyroid disease requiring surgery.
3
Frequent thyroid nodules have also been detected by ultrasound (US) in patients with secondary hyperparathyroidism (SHPT). 4 Other observations have indicated an increased risk for cancer in patients with PHPT, mainly of hematopoietic, breast, and urinary tract malignancies, but also endocrine neoplasms. 5, 6 endocrinopathies, the association between hyperparathyroidism and thyroid cancer has neither frequently reported nor widely discussed. Therefore, the clinical significance of concomitant thyroid cancer and hyperparathyroidism remains unclear.
The objective of this study was to explore the presumed association between PHPT, thyroid nodularity, and thyroid cancer by conducting an exemplar case series study, specifically addressing small ( 1 cm), otherwise "innocent," nonsuspicious thyroid nodules (by preoperative US and cytology) copresenting in patients with PHPT scheduled for parathyroidectomy that intra-and postoperative surgical pathology revealed as papillary thyroid carcinoma (PTC). Additionally, relevant observations retrieved from the English literature addressing thyroid cancer and hyperparathyroidism (both PHPT and SHPT) were reviewed, processed, and presented.
Methods
This work has been approved by the local Institutional Review Board. An exemplar group of patients diagnosed with PHPT was studied. All had both a preoperative 99m Tc-MIBI (methoxyisobutyl isonitrile) scan and neck US suggesting a single parathyroid adenoma and were scheduled for an elective parathyroidectomy. In addition, all preoperative US studies demonstrated a small, benign-appearing thyroid nodule. US-guided fine needle aspiration (FNA) results from these thyroid nodules were also reported to be benign (II, according the Bethesda system for reporting thyroid cytopathology).
7
All the patients were otherwise healthy, and none had any risk factors related to thyroid cancer according to the American Thyroid Association (ATA) 2009 guidelines (i.e., prior thyroid cancer, family history, or exposure to external irradiation).
8
All patients underwent surgery in which a parathyroid adenoma was excised. By addressing these patients with PHPT as extra-suspicious for PTC, the thyroid lesion was sent for an intraoperative frozen section pathologic examination, which confirmed PTC. Thus, as planned and discussed before surgery, with consent given, total thyroidectomy was performed in addition to the parathyroidectomy.
Results
The preoperative workup and intraoperative courses of the four patients are summarized in ►Table 1 and ►Table 2, respectively. The postoperative recovery and follow-up were uneventful in all patients; postoperative parathyroid hormone and calcium blood levels returned to normal values. Surgical pathology of all the thyroid lesions was reported as PTC, classical variant, without evidence for an extracapsular spread (►Table 2). Patient 3 had an uneventful completion thyroidectomy 2 weeks after the first surgery, whereas patient 4 decided not to have completion thyroidectomy. Patients 1, 2, and 3 were later referred for ablative iodine 131 treatment.
The MEDLINE electronic database was searched to identify relevant studies. For this purpose, we used the following free-text terms: "hyperparathyroidism" with "thyroid cancer" or "risk factor" or "hypercalcemia," and limited to "human." In addition, relevant studies were also extensively searched for by hand. Time and language limitations were applied to the years 1900 to 2014 and English, respectively. Data regarding the occurrence of thyroid nodules among patients with PHPT were reported to match the general population. 9,10 However, processing reported information regarding PTC among patients with PHPT who were operated for parathyroid adenoma suggested a 5% incidence rate of coexistence of thyroid cancer and PHPT. 
Discussion
This study questioned whether patients with PHPT have a higher risk for PTC in comparison with the general population. All the same, to date the ATA guidelines do not consider PHPT a risk factor for thyroid cancer. An increased awareness and earlier diagnosis of PHPT has been partially attributed to the popular routine automated biochemical testing, in addition to targeting middle-aged women with blood calcium screening in an aging society. 16 Furthermore, other reports suggested that patients with PHPT may have an elevated risk to encounter cancer including thyroid cancer. 5, 6 Concurrently, thyroid cancer incidence has been reported to increase worldwide. The reasons are not clear, yet an increased US detection rate of thyroid lesions is probably only a partial explanation. [17] [18] [19] [20] [21] When based on physical examination alone, the incidence of thyroid nodularity was estimated to be 6.4% among female subjects and 1.5% in male subjects, and the incidence of thyroid nodules was 37 to 57% in autopsies series, with similar figures when detected by US.
22
Contemporarily, FNA is the most valuable diagnostic procedure for PTC; however, false-negative results may be as high as 10%, especially in small, subcentimeter nodules.
23-25
This issue has been addressed by the revised ATA management guidelines for patients with thyroid nodules and differentiated thyroid cancer. These recommendations concluded that "routine FNA is not recommended for sub-centimeter nodules . . . patients for whom consideration of FNA of a subcentimeter nodule may be warranted include those with a higher likelihood of malignancy (high risk history), i.e., family history of PTC, history of external beam radiation exposure as a child, exposure to ionizing radiation in childhood or adolescence, history of prior hemithyroidectomy with discovery of thyroid cancer, and 18FDG-PET [fluorine-18 fluorodeoxyglucose positron emission tomography]-positive thyroid nodules." Regarding "size," the current study presented four patients with PHPT, without any ATA-recognized risk factors for thyroid cancer, who presented with a small, unsuspicious thyroid nodule, which would not have been studied otherwise but nevertheless proved to harbor PTC in the postoperative pathologic examination. Roti et al reported that tumors 10 mm accounted for 39% of all thyroid cancers, and local lymph node invasion occurred in 0.8% of tumors < 5 mm and in 1.6 to 3.3% of patients with nodules 6 to 10 mm in size.
26
Recent worldwide data reported the incidence of thyroid cancer to be $2 to 12 per 100,000 per year new cases, and the Although expressed in incomparable statistical measures, this rate suggests significance. Noteworthy are reports associating SHPT and thyroid cancer, thus contributing an additional argument that hyperparathyroidism may indeed predispose for thyroid cancer.
27-29
Finally, a nontraditional operative approach (i.e., obtaining an intraoperative biopsy of a small thyroid nodule with a benign preoperative cytology) in a high-risk patient (with PHPT) has been shown to be rewarding. It is important to note that the intraoperative examinations of the thyroid nodules have been proven to be reliable, as described in the same context.
30

Conclusion
Larger population studies are required to determine if hyperparathyroidism is a significant risk factor for PTC. At this time, we suggest that patients with PHPT should be regarded as extra-suspicious for PTC. Therefore, a comprehensive preoperative thyroid workup, including FNA, should be performed in all patients with PHPT, even for small thyroid nodules ( 1 cm). Despite an otherwise innocent preoperative evaluation of a thyroid nodule in patients with PHPT, flexible surgical planning with optional intraoperative thyroid tissue sampling should be considered during surgery.
